Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes

Christopher R. Cogle, Fatih M. Uckun, Daniel Turner et al.|British Journal of Haematology|2020

Cited by 15